389 related articles for article (PubMed ID: 21663997)
41. A randomized controlled trial on the efficacy of thoracic CT screening for lung cancer in non-smokers and smokers of <30 pack-years aged 50-64 years (JECS study): research design.
Sagawa M; Nakayama T; Tanaka M; Sakuma T; Sobue T;
Jpn J Clin Oncol; 2012 Dec; 42(12):1219-21. PubMed ID: 23042771
[TBL] [Abstract][Full Text] [Related]
42. Risk-benefit analysis of X-ray exposure associated with lung cancer screening in the Italung-CT trial.
Mascalchi M; Belli G; Zappa M; Picozzi G; Falchini M; Della Nave R; Allescia G; Masi A; Pegna AL; Villari N; Paci E
AJR Am J Roentgenol; 2006 Aug; 187(2):421-9. PubMed ID: 16861547
[TBL] [Abstract][Full Text] [Related]
43. Indolent, Potentially Inconsequential Lung Cancers in the Pittsburgh Lung Screening Study.
Thalanayar PM; Altintas N; Weissfeld JL; Fuhrman CR; Wilson DO
Ann Am Thorac Soc; 2015 Aug; 12(8):1193-6. PubMed ID: 26107281
[TBL] [Abstract][Full Text] [Related]
44. Characteristics and outcomes of small cell lung cancer patients diagnosed during two lung cancer computed tomographic screening programs in heavy smokers.
Cuffe S; Moua T; Summerfield R; Roberts H; Jett J; Shepherd FA
J Thorac Oncol; 2011 Apr; 6(4):818-22. PubMed ID: 21623258
[TBL] [Abstract][Full Text] [Related]
45. Development and Validation of Risk Models to Select Ever-Smokers for CT Lung Cancer Screening.
Katki HA; Kovalchik SA; Berg CD; Cheung LC; Chaturvedi AK
JAMA; 2016 Jun; 315(21):2300-11. PubMed ID: 27179989
[TBL] [Abstract][Full Text] [Related]
46. Radiation risk of lung cancer screening.
Frank L; Christodoulou E; Kazerooni EA
Semin Respir Crit Care Med; 2013 Dec; 34(6):738-47. PubMed ID: 24258564
[TBL] [Abstract][Full Text] [Related]
47. Noninvasive Computed Tomography-based Risk Stratification of Lung Adenocarcinomas in the National Lung Screening Trial.
Maldonado F; Duan F; Raghunath SM; Rajagopalan S; Karwoski RA; Garg K; Greco E; Nath H; Robb RA; Bartholmai BJ; Peikert T
Am J Respir Crit Care Med; 2015 Sep; 192(6):737-44. PubMed ID: 26052977
[TBL] [Abstract][Full Text] [Related]
48. Solitary and multiple resected adenocarcinomas after CT screening for lung cancer: histopathologic features and their prognostic implications.
Vazquez M; Carter D; Brambilla E; Gazdar A; Noguchi M; Travis WD; Huang Y; Zhang L; Yip R; Yankelevitz DF; Henschke CI;
Lung Cancer; 2009 May; 64(2):148-54. PubMed ID: 18951650
[TBL] [Abstract][Full Text] [Related]
49. Screening for lung cancer. Too many uncertainties, even for smokers.
Prescrire Int; 2014 Jan; 23(145):19-23. PubMed ID: 24516909
[TBL] [Abstract][Full Text] [Related]
50. [Risk factors for the development of lung cancer in a cohort of adult smokers].
Saldías Peñafiel F; Elola Aránguiz JM; Uribe Monasterio J; Morales Soto A; Díaz Patiño O
Rev Med Chil; 2016 Nov; 144(11):1382-1390. PubMed ID: 28394954
[TBL] [Abstract][Full Text] [Related]
51. Lung cancer screening with low-dose computed tomography after the National Lung Screening Trial. The debate is still open.
Ruano-Ravina A; Pérez Ríos M; Fernández-Villar A
Arch Bronconeumol; 2013 Apr; 49(4):158-65. PubMed ID: 23317766
[TBL] [Abstract][Full Text] [Related]
52. Characteristics and Outcomes of Small Cell Lung Cancer Detected by CT Screening.
Thomas A; Pattanayak P; Szabo E; Pinsky P
Chest; 2018 Dec; 154(6):1284-1290. PubMed ID: 30080997
[TBL] [Abstract][Full Text] [Related]
53. Prognostic value of tumor disappearance rate on computed tomography in advanced-stage lung adenocarcinoma.
Haraguchi N; Satoh H; Kikuchi N; Kagohashi K; Ishikawa H; Ohtsuka M
Clin Lung Cancer; 2007 Mar; 8(5):327-30. PubMed ID: 17562232
[TBL] [Abstract][Full Text] [Related]
54. Stopping Smoking Reduces Mortality in Low-Dose Computed Tomography Screening Participants.
Pastorino U; Boffi R; Marchianò A; Sestini S; Munarini E; Calareso G; Boeri M; Pelosi G; Sozzi G; Silva M; Sverzellati N; Galeone C; La Vecchia C; Ghirardi A; Corrao G
J Thorac Oncol; 2016 May; 11(5):693-699. PubMed ID: 26921675
[TBL] [Abstract][Full Text] [Related]
55. Screening for lung cancer.
Dominioni L; Strauss GM; Imperatori A; Rovera F; Dionigi G
Chest Surg Clin N Am; 2000 Nov; 10(4):729-36. PubMed ID: 11091922
[TBL] [Abstract][Full Text] [Related]
56. Low-dose computed tomography screening for lung cancer in a general population: characteristics of cancer in non-smokers versus smokers.
Li F; Sone S; Abe H; MacMahon H; Doi K
Acad Radiol; 2003 Sep; 10(9):1013-20. PubMed ID: 13678090
[TBL] [Abstract][Full Text] [Related]
57. Finding needles in a haystack: annual low-dose computed tomography screening reduces lung cancer mortality in a high-risk group.
Duke SL; Eisen T
Expert Rev Anticancer Ther; 2011 Dec; 11(12):1833-6. PubMed ID: 22117150
[TBL] [Abstract][Full Text] [Related]
58. Lung cancer screening.
Arenberg D
Semin Respir Crit Care Med; 2013 Dec; 34(6):727-37. PubMed ID: 24258563
[TBL] [Abstract][Full Text] [Related]
59. Lung cancer with localized ground-glass attenuation represents early-stage adenocarcinoma in nonsmokers.
Seki N; Sawada S; Nakata M; Inoue T; Nishimura R; Segawa Y; Shibakuki R; Eguchi K
J Thorac Oncol; 2008 May; 3(5):483-90. PubMed ID: 18449000
[TBL] [Abstract][Full Text] [Related]
60. Differences in Patient Outcomes of Prevalence, Interval, and Screen-Detected Lung Cancers in the CT Arm of the National Lung Screening Trial.
Schabath MB; Massion PP; Thompson ZJ; Eschrich SA; Balagurunathan Y; Goldof D; Aberle DR; Gillies RJ
PLoS One; 2016; 11(8):e0159880. PubMed ID: 27509046
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
